Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 9;80(6):631-640.
doi: 10.1016/j.jacc.2022.06.008.

Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review

Affiliations
Review

Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review

Gregory A Roth et al. J Am Coll Cardiol. .

Abstract

The impact of COVID-19 on the burden of cardiovascular diseases (CVD) during the early pandemic remains unclear. COVID-19 has become one of the leading causes of global mortality, with a disproportionate impact on persons with CVD. Studies of health facility admissions for CVD found significant decreases during the pandemic. Studies of hospital mortality for CVD were more variable. Studies of population-level CVD mortality differed across countries, with most showing decreases, although some revealed increases in deaths. In some countries where large increases in CVD deaths were reported in vital registration systems, misclassification of COVID-19 as CVD may have occurred. Taken together, studies suggest heterogeneous effects of the COVID-19 pandemic on CVD without large increases in CVD mortality in 2020 for a number of countries. Clinical and population science research is needed to examine the ways in which the pandemic has affected CVD burden.

Keywords: COVID-19; burden of disease; hospital outcomes; population health.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Funded by the Bill and Melinda Gates Foundation. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Central Illustration
Central Illustration
Percent Change in Cardiovascular Deaths, 2020 Compared With 2015 to 2019 The impact of COVID-19 on the burden of cardiovascular diseases (CVD) during the early pandemic remains unclear. Studies of population-level CVD mortality differed across countries, with most showing decreases, although some revealed small to moderate increases in deaths. These differences may be explained by the misclassification of COVID-19 as CVD in some countries. Taken together, studies suggest heterogenous effects of the COVID-19 pandemic on CVD without large increases in CVD mortality in 2020 for a number of countries.

Similar articles

Cited by

References

    1. Wang H., Paulson K.R., Pease S.A., et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet. 2022;399(10334):1513–1536. doi: 10.1016/S0140-6736(21)02796-3. - DOI - PMC - PubMed
    1. Roth G., Mensah G., Fuster V., et al. The global burden of cardiovascular diseases and risks. J Am Coll Cardiol. 2020;76(25):2980–2981. doi: 10.1016/j.jacc.2020.11.021. - DOI - PubMed
    1. Bonow R.O., Fonarow G.C., O’Gara P.T., Yancy C.W. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751–753. doi: 10.1001/jamacardio.2020.1105. - DOI - PubMed
    1. Giustino G., Pinney S.P., Lala A., et al. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar. J Am Coll Cardiol. 2020;76(17):2011–2023. doi: 10.1016/j.jacc.2020.08.059. - DOI - PMC - PubMed
    1. Bikdeli B., Madhavan M.V., Jimenez D., et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020;75(23):2950–2973. doi: 10.1016/j.jacc.2020.04.031. - DOI - PMC - PubMed

Publication types